 |
|
|
| |
Combination Therapy of Treatment-Naïve and Nonresponder Patients With HCV Genotype 1 Infection With Daclatasvir (DCV; BMS-790052), an NS5A Replication Complex Inhibitor, in Combination With Peginterferon Alfa-2a and Ribavirin
|
| |
| |
Reported by Jules Levin
AASLD Nov 5-9 2011 SF
Izumi N,1 Asahina Y,1 Yokosuka O,2 Imazaki F,2 Kawada N,3 Tamori A,3 Osaki Y,4 Kimura T,4 Yamamoto K,5 Takaki A,5 Sata M,6 Ide T,6 Ishikawa H,7 Ueki T,7 Yang R,8 McPhee F,8 Hughes E9
1Musashino Red Cross Hospital, Tokyo, Japan; 2Chiba University, Chiba, Japan; 3Osaka City University, Osaka, Japan; 4Osaka Red Cross Hospital, Osaka, Japan; 5Okayama University, Okayama, Japan; 6Kurume University, Kurume, Japan; 7Bristol-Myers KK, Tokyo, Japan; 8Bristol-Myers Squibb, Wallingford, CT; 9Bristol-Myers Squibb Research & Development, Princeton, NJ
|
| |
|
|
|
|
|
